Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SPRO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
SPRO
Spero Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
SPRO
Spero Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
SPRO
Spero Therapeutics, Inc.
Change
1.07
▲
+4.41%
· post 1.04
Mkt cap
$59.4M
Revenue
$258,000
Q1 FY26
Revenue
$67M
FY25
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Closed
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 6 '26
SPRO
Spero Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
1.07
▲
+4.41%
post 1.04
Price
1,360.90
▼
−0.28%
post 1,358.90
$59.4M
Mkt cap
$1.2T
Q1 FY26
$258,000
Revenue
$24.4B
Q3 FY26
FY25
$67M
Revenue
$65.2B
FY25
Change
Change
SPRO
1.07
▲
+4.41%
vs
LLY
1,360.90
▼
−0.28%
Closed
Nov 6 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SPRO, solid
LLY, dashed